RNS Number : 5926U
  Hikma Pharmaceuticals Plc
  15 May 2008
   

    Hikma Pharmaceuticals PLC - Results of Annual General Meeting

    LONDON, 15 May 2008 - Hikma Pharmaceuticals PLC ("the Company") advises that at its Annual General Meeting of shareholders, held at the
Andaz Hotel, 40 Liverpool Street, London, that began at 11.00am today, 15 May 2008, resolutions 1 to 7 contained in the Notice of Annual
General Meeting were passed as ordinary resolutions on a show of hands. Resolutions 8 and 9 were passed as special resolutions on a show of
hands 

    
    Copies of the resolutions dealing with special business passed at the Annual General Meeting have been submitted to the UK Listing
Authority for publication through the Listing Authority's Document and Viewing Facility.  

    The total number of proxies received for each resolution is set out below. The total number of votes received for each resolution is set
out below. The number of Ordinary Shares in issue on 15 May 2008 was 188,588,607.

     Resolution                   Votes  %      Votes Against  %     Discretion  %      Votes Withheld
                                  For 
 1   To receive the 2007   80,463,625    63.89  267,877        0.21  46,350,091  35.90    86,857
     report and accounts
 2   To declare a final    80,735,343    64.06  83,016         0.07  46,350,091  35.87        -
     dividend
 3   Reappointment of Mr   78,552,076    63.43  85,403         0.07  46,350,091  36.50  2,180,880
     Said Darwazah
 4   Reappointment of      80,576,256    64.02  82,324         0.06  46,350,091  35.92    159,779
     Deloitte and Touche
     as auditors 
 5   Authorise the         80,732,985    64.06  85,324         0.07  46,350,091  35.87    50
     directors to set the
     remuneration of the
     auditors
 6   To receive and        80,544,132    64.05  8,079          0.01  46,350,091  35.94    266,148
     approve the
     Remuneration Report
 7   Authorise the         77,910,142    61.82  2,908,217      2.31  46,350,091  35.87        -
     directors to allot
     shares
 8   Disapply pre-emption  78,062,847    61.94  2,230,120      1.77  46,875,483  36.29        -
     rights
 9   Amend the Articles    77,716,543    61.80  2,311,526      1.84  46,875,483  36.36    264,898
     of Association

    Notes:
    *     The discretionary votes granted to the Chairman were voted in favour of the resolutions. 

    *     A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a
resolution.    

    Declaration of final dividend

    The final dividend of 4.0 cents per share will be paid on 2 June 2008 to shareholders on the register on 2 May 2008. Shareholders who
are not resident in Jordan have been given the option of receiving their dividend in Pounds Sterling. The exchange rate in respect of this
dividend is 1.9480 US dollars to one Pound Sterling, equal to approximately 2.05 pence per share. Shareholders resident in Jordan have been
given the opportunity to receive the dividend in Jordanian Dinar, at a rate of 0.708 Jordanian Dinar per US dollar.


    - ENDS -


    Enquiries:

 Hikma Pharmaceuticals PLC
 Henry Knowles              +44 20 7399 2670
 Company Secretary

 Susan Ringdal              +44 20 7399 2670
 Investor Relations
 Director


 Brunswick Group
 Jon Coles / Justine McIlroy / Alex Tweed  +44 20 7404 5959


    About Hikma
    Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both
branded and non-branded generic and in-licensed pharmaceutical products.  Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics".  Hikma's operations are based principally in the Middle East and North Africa ("MENA") region,
where it is a market leader and sells across 17 countries, the United States and Europe.  In 2007, the Group achieved revenues of $449
million (2006 $317 million) and profit attributable to shareholders was $63 million (2006 $55 million).  For news and other information,
please visit www.hikma.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RAGSFIFMISASESI
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.